Title: The CORCINCH-HF Study
Purpose: This is a prospective, randomized, open-label, multicenter, international, clinical safety and efficacy investigation of the AccuCinch Ventricular Restoration System. The objective of this study is to evaluate the safety and efficacy of the AccuCinch Ventricular Restoration System in patients with symptomatic heart failure with reduced ejection fraction (HFrEF).
Study Location: Jackson Heart Clinic and St. Dominic Jackson Memorial Hospital.
Principle Investigator: Dr. William Crowder
Contact: For more information, please contact the research office at (225) 765-7659 or via email at research@fmolhs.org.
Open for Enrollment at St. Dominic Health
Purpose: This is a prospective, multicenter, randomized clinical study. The Encore PFO closure device is indicated for percutaneous, transcatheter closure of a patent foramen ovale (PFO) in patients, predominantly between the ages of 18 and 60 years, who have had a cryptogenic stroke due to a presumed paradoxical embolism.
Study Location: Jackson Heart Clinic and St. Dominic Jackson Memorial Hospital.
Principle Investigator: Dr. William Crowder
Contact: For more information, please contact the research office at (225) 765-7659 or via email at research@fmolhs.org.
Open for Enrollment
Explore oncology clinical trials by disease type. Our program offers access to cutting-edge therapies, including Phase I and cellular therapies.
Title: Exact Sciences 2021-05 Tissue and Blood Biomarker Study
Purpose: This is a prospective, observational blood and formalin-fixed paraffin-embedded (FFPE) tumor tissue specimen collection study to evaluate biomarkers in subjects with cancer.
Study Location: Jackson Heart Clinic and St. Dominic Jackson Memorial Hospital.
Principle Investigator: Dr. Donald Seago and Dr. Christy Haygood
Contact: For more information, please contact the research office at (225) 765-7659 or via email at research@fmolhs.org.
Open for Enrollment
Title: Merck- GOG 3036 Study
Purpose: A Randomized Phase 3, Double-Blind Study to assess the efficacy and safety of treatment with carboplatin/paclitaxel* PLUS pembrolizumab (MK-3475) and maintenance olaparib (MK-7339) in women with epithelial ovarian cancer (EOC), fallopian tube cancer, or primary peritoneal cancer.
Study Location: Jackson Heart Clinic and St. Dominic Jackson Memorial Hospital.
Principle Investigator: Dr. Donald Seago and Dr. Christy Haygood
Contact: For more information, please contact the research office at (225) 765-7659 or via email at research@fmolhs.org.
Open for Enrollment